BeStock  

Dentsply Sirona XRAY

US equityMarket cap rank #2811Medical Instruments & Supplies
$8.29 −$0.20 (-2.36%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $8.34 +0.60%
Open$8.45
Prev close$8.49
Day range$8.24 – $8.74
Volume4.88M
Market cap$1.64B
P/E (TTM)–
Dividend yield1.93%

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$836.00M-7.5% YoY
Operating profit$37.00M-19.6% YoY
Net profit-$3.00M+99.3% YoY
Diluted EPS-$0.01+99.5% YoY
Free cash flow$0.00-100.0% YoY
Operating cash flow$32.00M

Revenue, last 8 quarters

$905.0MDec '24$879.0MMar '25$936.0MJun '25$904.0MSep '25$961.0MDec '25$880.0MMar '26$898.0MJun '26$836.0MSep '26

Net profit, last 8 quarters

$-428.0MDec '24$19.0MMar '25$-44.0MJun '25$-428.0MSep '25$-145.0MDec '25$-10.0MMar '26$36.0MJun '26$-3.0MSep '26

Diluted EPS by quarter

-2.16Dec '240.10Mar '25-0.22Jun '25-2.14Sep '25-0.74Dec '25-0.05Mar '260.18Jun '26-0.01Sep '26

Free cash flow by quarter

$36.0MDec '24$-12.0MMar '25$16.0MJun '25$40.0MSep '25$60.0MDec '25$-12.0MMar '26$55.0MJun '26$0.0Sep '26

Annual revenue

$3.3BFY20$4.2BFY21$3.9BFY22$4.0BFY23$3.8BFY24$3.7BFY25

Profitability & balance sheet

Gross margin50.5%
Operating margin4.9%
Net margin-3.4%
Return on equity-8.5%
Return on assets-2.2%
Return on invested capital-1.7%
Current ratio1.63
Liabilities / assets73.9%
Cash & investments$195.00M
Total debt$2.29B
Net cash (debt)-$2.09B
Free cash flow / sales2.9%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Essential Dental Solutions$343.00M 41.0%
  • Connected Technology Solutions$230.00M 27.5%
  • Orthodontic and Implant Solutions$171.00M 20.5%
  • Wellspect Healthcare$92.00M 11.0%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $836.00M $898.00M $880.00M $3.68B $961.00M
Total Operating Revenue $836.00M $898.00M $880.00M $3.68B $961.00M
Cost of Revenue $393.00M $405.00M $453.00M $1.84B $518.00M
Gross Profit $443.00M $493.00M $427.00M $1.84B $443.00M
Operating Expense $406.00M $410.00M $397.00M $1.59B $418.00M
Selling and Admin Expenses $364.00M $365.00M $353.00M $1.44B $378.00M
-General & Admin Expense $364.00M $365.00M $353.00M – –
Research & Development $42.00M $45.00M $44.00M $150.00M $40.00M
Operating Profit $37.00M $83.00M $30.00M $252.00M $25.00M
Net Non-Operating Interest Income (Expense) -$25.00M -$22.00M -$24.00M -$88.00M -$22.00M
Non-Operating Interest Expense $25.00M $22.00M $24.00M $88.00M $22.00M
Other Income (Expense) $14.00M $11.00M -$48.00M -$650.00M -$150.00M
Gain on Sale of Security $15.00M $13.00M $13.00M $32.00M $19.00M
Special Income (Charges) -$1.00M -$2.00M -$67.00M -$674.00M -$159.00M
-Less:Restructuring and Mergern & Acquisition -$2.00M $2.00M $67.00M $24.00M $6.00M
-Less:Impairment of Capital Assets $3.00M $0.00 – $650.00M $153.00M
Pretax Profit $26.00M $72.00M -$42.00M -$486.00M -$147.00M
Tax $29.00M $36.00M -$32.00M $112.00M -$2.00M
Net Profit -$3.00M $36.00M -$10.00M -$598.00M -$145.00M
Profit from Continuing Operations -$3.00M $36.00M -$10.00M -$598.00M -$145.00M
Minority Interests -$1.00M -$1.00M $0.00 $0.00 $1.00M
Net Income to Parent Company -$2.00M $37.00M -$10.00M -$598.00M -$146.00M
Net Income to Common Stockholders -$2.00M $37.00M -$10.00M -$598.00M -$146.00M
Basic EPS -$0.01 $0.18 -$0.05 -$3.00 -$0.74
Diluted EPS -$0.01 $0.18 -$0.05 -$3.00 -$0.74
Dividend Per Share $0.00 $0.00 $0.00 $0.64 $0.16
Other Non-Operating Income (Expenses) – – $6.00M -$8.00M -$10.00M

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $5.19B $5.20B $5.23B $5.43B $5.43B
Total Current Assets $1.98B $1.93B $1.85B $2.02B $2.02B
Cash and Cash Equivalents & Short-Term Investments $195.00M $239.00M $190.00M $326.00M $326.00M
-Cash and Cash Equivalents $195.00M $239.00M $190.00M $326.00M $326.00M
Receivables $605.00M $620.00M $622.00M $737.00M $737.00M
-Accounts Receivable $605.00M $620.00M $622.00M $688.00M $688.00M
Inventory $707.00M $665.00M $659.00M $642.00M $642.00M
Other Current Assets $471.00M $404.00M $374.00M $150.00M $150.00M
Total Non-Current Assets $3.21B $3.28B $3.38B $3.41B $3.41B
Net PPE $971.00M $974.00M $997.00M $1.00B $1.00B
-Gross PPE $971.00M $974.00M $997.00M $2.57B $2.57B
Goodwill and Other Intangible Assets $1.95B $2.01B $2.07B $2.12B $2.12B
-Goodwill $1.14B $1.14B $1.14B $1.15B $1.15B
-Other Intangible Assets $815.00M $870.00M $924.00M $974.00M $974.00M
Other Non-Current Assets $290.00M $294.00M $321.00M $284.00M $284.00M
Total Liabilities $3.84B $3.85B $3.91B $4.09B $4.09B
Total Current Liabilities $1.22B $1.19B $1.21B $1.34B $1.34B
Payables $296.00M $293.00M $289.00M $330.00M $330.00M
-Accounts Payable $238.00M $260.00M $259.00M $300.00M $300.00M
-Total Tax Payable $58.00M $33.00M $30.00M $30.00M $30.00M
Current Accrued Expenses $706.00M $664.00M $688.00M $260.00M $260.00M
Short-Term Debt and Capital Lease Obligation $215.00M $228.00M $230.00M $360.00M $360.00M
-Current Debt $215.00M $228.00M $230.00M $313.00M $313.00M
Total Non-Current Liabilities $2.62B $2.67B $2.70B $2.75B $2.75B
Long Term Debt and Capital Lease Obligation $2.07B $2.08B $2.10B $2.11B $2.11B
-Long Term Debt $1.99B $2.00B $2.01B $2.02B $2.02B
-Long Term Capital Lease Obligation $87.00M $88.00M $95.00M $93.00M $93.00M
Non-Current Deferred Liabilities $74.00M $79.00M $84.00M $94.00M $94.00M
Other Non-Current Liabilities $473.00M $505.00M $518.00M $544.00M $544.00M
Total Equity $1.35B $1.35B $1.32B $1.34B $1.34B
Stockholders' Equity $1.36B $1.35B $1.32B $1.34B $1.34B
Capital Stock $3.00M $3.00M $3.00M $3.00M $3.00M
-Common Stock $3.00M $3.00M $3.00M $3.00M $3.00M
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $6.62B $6.62B $6.62B $6.64B $6.64B
Retained Earnings -$1.54B -$1.54B -$1.57B -$1.56B -$1.56B
Less: Treasury Stock -$3.08B -$3.08B -$3.07B -$3.11B -$3.11B
Gains/Losses Not Affecting Retained Earnings -$647.00M -$656.00M -$655.00M -$639.00M -$639.00M
Minority Interests -$1.00M $0.00 $1.00M $1.00M $1.00M
-Taxes Receivable – – – $49.00M $49.00M
Prepaid Assets – – – $168.00M $168.00M
-Accumulated Depreciation – – – -$1.57B -$1.57B
-Current Capital Lease Obligation – – – $47.00M $47.00M
Current Provisions – – – $118.00M $118.00M
Current Deferred Liabilities – – – $74.00M $74.00M
Other Current Liabilities – – – $30.00M $30.00M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $32.00M $99.00M $40.00M $235.00M $101.00M
Net cash flow from continuing operations $32.00M $99.00M $40.00M $235.00M $101.00M
Net Income from Continuing Operations -$3.00M $36.00M -$10.00M -$598.00M -$145.00M
Gain/Loss from Continuing Operations -$1.00M $0.00 -$6.00M – –
Depreciation & Depletion & Amortization $82.00M $85.00M $79.00M $352.00M $93.00M
Deferred Tax -$8.00M $18.00M -$60.00M $30.00M -$14.00M
Other Non-Cash Items $16.00M $2.00M -$15.00M -$10.00M -$23.00M
Change in Working Capital -$65.00M -$51.00M $44.00M -$222.00M $29.00M
-Change in Receivables $11.00M -$4.00M $60.00M -$91.00M -$35.00M
-Change in Inventory -$46.00M -$9.00M -$23.00M -$17.00M $44.00M
-Change in Prepaid Assets $6.00M -$30.00M $19.00M -$7.00M $3.00M
-Change in Payables and Accrued Expense -$60.00M -$4.00M -$18.00M -$63.00M $12.00M
-Change in Other Current Assets $0.00 -$3.00M $1.00M -$7.00M -$7.00M
-Change in Other Current Liabilities -$2.00M $2.00M -$2.00M -$5.00M -$1.00M
-Change In Other Working Capital $26.00M -$3.00M $7.00M -$32.00M $13.00M
Net cash flow from investing -$43.00M -$39.00M -$53.00M -$132.00M -$45.00M
Net Cash Flow from Continuing Investing Activities -$43.00M -$39.00M -$53.00M -$132.00M -$45.00M
Capital Expenditure -$32.00M -$44.00M -$52.00M -$131.00M -$41.00M
Net PPE Purchase and Sale -$1.00M – – – –
Net Investment Purchase and Sale -$9.00M -$1.00M -$7.00M -$4.00M -$5.00M
Net Other Investing Changes -$1.00M $1.00M $6.00M $3.00M $1.00M
Financing Cash Flow -$28.00M -$11.00M -$119.00M -$80.00M -$99.00M
Net Cash Flow from Continuing Financing Activities -$28.00M -$11.00M -$119.00M -$80.00M -$99.00M
Net Issuance Payments Of Debt -$14.00M $1.00M -$82.00M $70.00M -$62.00M
Net Common Stock Issuance -$13.00M – – $0.00 $0.00
Cash Dividends Paid $0.00 $0.00 -$32.00M -$128.00M -$32.00M
Net Other Financing Charges -$1.00M $0.00 -$5.00M -$22.00M -$5.00M
Ending Cash Balance $195.00M $239.00M $190.00M $326.00M $326.00M
Net Change in Cash -$39.00M $49.00M -$132.00M $23.00M -$43.00M
Beginning Cash Balance $239.00M $190.00M $326.00M $272.00M $363.00M
Effect of Exchange Rate Changes -$5.00M $0.00 -$4.00M $31.00M $6.00M
Free Cash Flow $0.00 $55.00M -$12.00M $104.00M $60.00M
Net Business Purchase and Sale – – – $0.00 –

Discussion

No comments yet — be the first to weigh in on XRAY.

Sign in to join the discussion.

Scroll to Top